Medical Devices Global

Global Antimicrobial Resistance Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Global Antimicrobial Resistance Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Global · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $3.21 Bn Placeholder estimate
Estimate 2025 $3.43 Bn Placeholder estimate
Projected 2034 $6.31 Bn 83.8% Adds $2.88 Bn over 9 forecast years
CAGR 2025–2034 7.0% Faster than 24% of 173 Medical Devices markets here
Key players 5
  • Worldwide, the largest is US at $1.46 Bn.
  • Fastest growing: India at 10% a year.

Market size projection

Global

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.88 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Antimicrobial Resistance Diagnostics Market market size by year, Global
YearMarket sizeChange that yearSince 2025
2024 (estimate) $3.21 Bn — —
2025 (base) $3.43 Bn +$224.7 Mn —
2026 (forecast) $3.68 Bn +$240.4 Mn +7%
2027 (forecast) $3.93 Bn +$257.3 Mn +14.5%
2028 (forecast) $4.21 Bn +$275.3 Mn +22.5%
2029 (forecast) $4.50 Bn +$294.5 Mn +31.1%
2030 (forecast) $4.82 Bn +$315.2 Mn +40.3%
2031 (forecast) $5.15 Bn +$337.2 Mn +50.1%
2032 (forecast) $5.52 Bn +$360.8 Mn +60.6%
2033 (forecast) $5.90 Bn +$386.1 Mn +71.8%
2034 (forecast) $6.31 Bn +$413.1 Mn +83.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Global Antimicrobial Resistance Diagnostics Market Analysis at a glance
Market size, 2025$3.43 Bn placeholder estimate
Forecast, 2034$6.31 Bn placeholder estimate
Growth (CAGR), 2025–20347.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, setting and end user (see all)
Key playersbioMérieux SA, BD (Becton, Dickinson), Beckman Coulter (Danaher), Accelerate Diagnostics, Inc., Thermo Fisher Scientific Inc. (see all)
Regulator worldwideIMDRFSource: International Medical Device Regulators Forum. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Global Antimicrobial Resistance Diagnostics Market Analysis Executive Summary

Antimicrobial resistance diagnostics show which antibiotics will work against an infection, helping doctors avoid ineffective drugs.

Key segments of the antimicrobial Resistance Diagnostics market include technology (Automated AST Systems, Molecular Resistance Tests and Rapid Phenotypic AST) and setting (Hospital Labs and Reference Labs).

Bar chart: Global Antimicrobial Resistance Diagnostics market size, 2024–2034, placeholder estimates. $3.21 Bn in 2024, $3.43 Bn in 2025 and $6.31 Bn in 2034, 7.0% CAGR.
Global Antimicrobial Resistance Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Global Antimicrobial Resistance Diagnostics Market Dynamics

Market Growth Drivers

Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the antimicrobial Resistance Diagnostics market.

Opportunity

New vaccines, rapid tests and public-private funding for neglected diseases give the antimicrobial Resistance Diagnostics market room to grow, especially in Asia, Africa and Latin America.

Market Restraints

Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the antimicrobial Resistance Diagnostics market.

Competitive Landscape for Antimicrobial Resistance Diagnostics Market in Global

The antimicrobial Resistance Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Antimicrobial Resistance Diagnostics Market in Global

Antimicrobial Resistance Diagnostics worldwide: rules and payment

There is no single global regulator; the International Medical Device Regulators Forum (IMDRF) helps national regulators align their device rules.⁠[1] WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.⁠[2]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how antimicrobial Resistance Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Global.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Antimicrobial Resistance Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Antimicrobial Resistance Diagnostics in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Antimicrobial Resistance Diagnostics market worldwide?
Placeholder estimate: about $3.43 Bn in 2025, rising to about $6.31 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Antimicrobial Resistance Diagnostics market worldwide growing?
Placeholder estimate: about 7.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Antimicrobial Resistance Diagnostics market report cover?
The report splits the market by technology (Automated AST Systems, Molecular Resistance Tests, Rapid Phenotypic AST), setting (Hospital Labs, Reference Labs) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Antimicrobial Resistance Diagnostics market?
Key players include bioMérieux SA, BD (Becton, Dickinson), Beckman Coulter (Danaher), Accelerate Diagnostics, Inc. and Thermo Fisher Scientific Inc..
What is driving the Antimicrobial Resistance Diagnostics market?
Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the antimicrobial Resistance Diagnostics market.
Who regulates Antimicrobial Resistance Diagnostics worldwide?
There is no single global regulator; the International Medical Device Regulators Forum (IMDRF) helps national regulators align their device rules. Source: International Medical Device Regulators Forum. Checked 14 Nov 2026.
How is healthcare paid for worldwide?
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021. Source: World Health Organization, universal health coverage. Checked 14 Nov 2026.
How much research is published on Antimicrobial Resistance Diagnostics?
PubMed lists 20 papers on Antimicrobial Resistance Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Global

See all

Related on antibiotics and diagnostics and lab testing

See the topic